Article Information
vol. 7 no. 3
Published By
Online ISSN
History
- Received March 18, 2021
- Accepted June 24, 2021
- Published online September 13, 2021.
Article Versions
- previous version (July 8, 2021 - 08:58).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Zhenyu Liang1,
- Nanshan Zhong1,
- Rongchang Chen2,
- Qianli Ma3,
- Yongchang Sun4,
- Fuqiang Wen5,
- Ruth Tal-Singer6,10,
- Bruce E. Miller6,10,
- Julie Yates7,10,
- Jie Song8,
- Chris Compton9,
- Beulah Ji8,
- Li Wu8,
- Yang Yang8,
- Paul Jones9⇑ and
- Jinping Zheng1
- 1State Key Laboratory of Respiratory Disease and National Clinical Research Center of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China
- 2Pulmonary and Critical Care Dept, Shenzhen Institute of Respiratory Diseases, First Affiliated Hospital of South University of Science and Technology of China (Shenzhen People's Hospital), Shenzhen, Guangdong, China
- 3Chronic Respiratory Disease Care Centre, The North Kuanren General Hospital, Chongqing, China
- 4Dept of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China
- 5Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, and Dept of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, China
- 6GlaxoSmithKline, Collegeville, PA, USA
- 7GlaxoSmithKline, Research Triangle Park, NC, USA
- 8GlaxoSmithKline, Research and Development, Shanghai, China
- 9GlaxoSmithKline, Brentford, UK
- 10No longer employees of GSK but were during the design of this study
- Corresponding author: Paul Jones (pjones{at}sgul.ac.uk)
Funding
GSK and National Key R&D Program of China
2018YFC1311900, 2017YFC1310600